One of the more aggressive and worst types of cancer is neuroendocrine carcinoma of colon. The worst part of this disease is that it is usually detected in its late stages when it is extremely hard to do anything about it.

As the side effects of neuroendocrine colon cancer become visible only in the most advanced stages the rate of survival of the patient drops drastically Existing tumours are always malignant, and mostly detected with distant metastases. Surveys show the reports have revealed that most of the cases of neuroendocrine cancer end in death.

Though the possibilities of neuroendocrine carcinoma in colon are very rare, if unfortunately one is affected by this disease, the health of the patient appears even worse than those who are suffering from adenocarcinoma.

Research reveals that the end results of this form of cancer stay the same with age, sex or tumour location. However, neuroendocrine colon carcinoma will depend heavily on the tumour’s stage. Standard cases have revealed that people in stage 1 and 2 of cancer usually do not suffer from neuroendocrine colon cancer. On the other hand, in several cases, if the tumour is in stage 3 or 4, it is a laborious and hard task the neuroendocrine colon carcinoma.

It is unfortunate that medical science has developed no adequate methods to treat this kind of cancer. A more common technique that doctors regularly use is immunohistochemical staining methods. This method helps doctors with coping with the severity of the neuroendocrine colon cancer and helps to determine the best medication and a treatment for it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. This involves staining of the tumour with the antibody A-80 which helps to identify the quantum of neuroendocrine differentiation and nature of the damage on the health of the patient.

Neuroendocrine colon carcinoma is cumbersome to deal with and in a certain study in which a number of patients suffered from colon carcinoma were extensively examined it was observed that the overall survival rate related to this disease was approximately seven months. In the later stages these rates decrease, to as low as five months or less. Most cases were at first found to be as carcinoids but they later developed in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer has a bad prognosis and surgery is not a cent percent guaranteed treatment so surgery may not even provide a satisfactory cure. So it is critical to detect this disease on time and provide proper medication for it.

To learn more about the best Colon clenz. Visit our site Ultra colon clenz.

Tags: Cancer

Share This